Christopher P Webster

5PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 05, 2024
RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD.

Christopher P Webster, Bradley Hall, Olivia M Crossley

|Oct 02, 2024
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47.

Jessica P Wiseman, Joseph M Scarrott, João Alves-Cruzeiro

|Jul 25, 2022
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.

Claudia S Bauer, Rebecca N Cohen, Francesca Sironi

|May 14, 2022
C9ORF72-derived poly-GA DPRs undergo endocytic uptake in iAstrocytes and spread to motor neurons.

Paolo M Marchi, Lara Marrone, Laurent Brasseur

|Apr 20, 2022
SMN-deficient cells exhibit increased ribosomal DNA damage.

Evangelia Karyka, Nelly Berrueta Ramirez, Christopher P Webster

Pageof 1